Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I never saw it.
OTCmarkets.com had an OS of around 75 million prior to this week.
Traders are making a killing dumping shares to unsuspecting peeps who fall for the pump here... and have been since May at .10.... What a shame...
This has been posted many times.
What ? How do you figure
Just being honest here
The 10q stated 23 million
Todays update states 59 million
The article has a 16 cent short term target.
GRCK
Thanks sir. clarifies that the suspicious email that a poster received is in fact what the company truly said
GRCK
Disclosure statement on Emerging growth website says the company gave them the October 10th timeframe
GRCK
CAN MOD CHANGE STICKY POST #2944 to #3331 THANKS!
GRCK
.01 is where this is heading without news!
Amazing DD thanks for sharing
It's a promo too. Sweet. Mucho Dinero coming$$$
GRCK
Tweet that now!!! Blow up Twitter.
ACQUISITION CONFIRMED TO CLOSE ON THE 10TH NEXT TUESDAY:
Go to Eqova website:
https://eqova.com/eqova-acquisition/
Then click on the link to their Facebook page:
https://www.facebook.com/eqova/
Then click on the article they posted:
http://emerginggrowth.com/greycloak-otc-pink-grck-flies-high-new-hempoil-acquisition-target-eqova-life-sciences/
I'm headed there now.
Great. Just don't bid whack your 100 shares tomorrow.
Thanks
oooo I didn't see that
GRCK
go to the website the header right on top says loi signed to be acquired by grey cloack ticker :grck
Its right there
OS has been reduced by 15 million in the last week according to otcmarkets.com via transfer agent.
more like 14s/13s for this POS!!
Why? How do you know? Just an FYI I have a position but I'm skeptical.
massive dilution-it couldn't hold any morning gains
This stock will run tomorrow and Monday for sure.
GRCK
That's a really nice bullish pennant forming there dude thanks for the chart
GRCK
OH NO MUST BE A SCAM THEN -drugdoctor
GRCK
They spelled Cloak wrong.
JUST RECEIVED EMAIL FROM EQOVA CONFIRMS MERGER:
(I am new to this stock so it has probably already been confirmed numerous times but I had to check for myself)
Thank so drugdoctor. Looks GREAT. .10 SOOOOOONN
Better do your due diligence - check the REVENUE projections.... GLTA
Meanwhile.... Insiders make huge salaries selling shares.... NICE!!!!
And how is that working??? Great??? Only if you are are on the receiving end of the INSIDER SALARY GRAVY TRAIN
LOL LOL
https://www.sec.gov/Archives/edgar/data/1630176/000152013817000282/grck-20170630_10q.htm
NOTE 3 – GOING CONCERN
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated minimal revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring start up costs and expenses. As a result, the Company incurred accumulated net losses from Inception (December 19, 2014) through the period ended June 30, 2017 of $4,750,949. In addition, the Company’s development activities since inception have been financially sustained through equity financing. Management plans to seek funding through debt and equity financing.
LOL LOL - and where does the money go??? LMAO - of course - to the insiders for their hard work of generating how much REVENUE???
$37,500 REVENUE.... LMAO
NOTE 4 – RELATED PARTY
For the six months ended June 30, 2017 and 2016, the Company had expenses totaling $52,000 and $48,000, respectively, to an officer and director for salaries, which is included in general and administrative expenses – related party on the accompanying statement of operations. As of June 30, 2017, there was $0 in accounts payable – related party.
For the three months ended June 30, 2017, the Company had expenses totaling $24,000 to an officer and director for salaries.
For the six months ended June 30, 2017 and 2016, the Company had expenses totaling $57,000 and $43,650, respectively, to a company owned by an officer and director for consulting fees, which is included in general and administrative expenses – related party on the accompanying statement of operations. As of June 30, 2017, there was $23,799 in accounts payable – related party.
For the three months ended June 30, 2017, the Company had expenses totaling $28,500 to a company owned by an officer and director for consulting fees.
NET LOSS - ($131,479)
No accumulation chart today?
with such a small market cap and with so much potential for 2018.......we should all look at the big picture when marijuana becomes legal for many millions of people and the importance of these products becoming available to people who do not want to smoke but ingest safe reputable products.
grck has its feet on solid ground and it will explode in time
Here's-the-truth-OUCH-PAYING-HUGE-SALARIES-TO-INSIDERS-With-SHARE-SELLS!
Read it and weep folks... it's all right here in the SEC filings... LOL LOL - What a scam!!!
https://www.sec.gov/Archives/edgar/data/1630176/000152013817000282/grck-20170630_10q.htm
NOTE 3 – GOING CONCERN
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated minimal revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring start up costs and expenses. As a result, the Company incurred accumulated net losses from Inception (December 19, 2014) through the period ended June 30, 2017 of $4,750,949. In addition, the Company’s development activities since inception have been financially sustained through equity financing. Management plans to seek funding through debt and equity financing.
LOL LOL - and where does the money go??? LMAO - of course - to the insiders for their hard work of generating how much REVENUE???
$37,500 REVENUE.... LMAO
NOTE 4 – RELATED PARTY
For the six months ended June 30, 2017 and 2016, the Company had expenses totaling $52,000 and $48,000, respectively, to an officer and director for salaries, which is included in general and administrative expenses – related party on the accompanying statement of operations. As of June 30, 2017, there was $0 in accounts payable – related party.
For the three months ended June 30, 2017, the Company had expenses totaling $24,000 to an officer and director for salaries.
For the six months ended June 30, 2017 and 2016, the Company had expenses totaling $57,000 and $43,650, respectively, to a company owned by an officer and director for consulting fees, which is included in general and administrative expenses – related party on the accompanying statement of operations. As of June 30, 2017, there was $23,799 in accounts payable – related party.
For the three months ended June 30, 2017, the Company had expenses totaling $28,500 to a company owned by an officer and director for consulting fees.
NET LOSS - ($131,479)
The Medical $cience Propelling GRCK - Dr. Paul Dragul ENT Otolaryngologist
I believe that we are obsessed with the second, minute and daily stock price but lets view the larger horizon.
Medical Professionals over the years have witnessed the health benefits of ingesting CBD Oils and one considers if Dr. Paul, has treated many a patient over a 40 year time span to be convinced that the benefits of engaging in Cannabinoid Therapy's exceed the negative connotations or prosecution till recent North American Governments sanctioned such a prescription protocol.
Remember, all Doctors take the sacred Hippocratic Oath.....
https://en.wikipedia.org/wiki/Hippocratic_Oath
"First Do No Harm"
I swear to fulfill, to the best of my ability and judgment, this covenant:
I will respect the hard-won scientific gains of those physicians in whose steps I walk, and gladly share such knowledge as is mine with those who are to follow.
I will apply, for the benefit of the sick, all measures [that] are required, avoiding those twin traps of overtreatment and therapeutic nihilism.
I will remember that there is art to medicine as well as science, and that warmth, sympathy, and understanding may outweigh the surgeon's knife or the chemist's drug.
I will not be ashamed to say "I know not," nor will I fail to call in my colleagues when the skills of another are needed for a patient's recovery.
I will respect the privacy of my patients, for their problems are not disclosed to me that the world may know. Most especially must I tread with care in matters of life and death. If it is given me to save a life, all thanks. But it may also be within my power to take a life; this awesome responsibility must be faced with great humbleness and awareness of my own frailty. Above all, I must not play at God.
I will remember that I do not treat a fever chart, a cancerous growth, but a sick human being, whose illness may affect the person's family and economic stability. My responsibility includes these related problems, if I am to care adequately for the sick.
I will prevent disease whenever I can, for prevention is preferable to cure.
I will remember that I remain a member of society, with special obligations to all my fellow human beings, those sound of mind and body as well as the infirm.
If I do not violate this oath, may I enjoy life and art, respected while I live and remembered with affection thereafter. May I always act so as to preserve the finest traditions of my calling and may I long experience the joy of healing those who seek my help.
We all know medical professionals professionally and personally.
DR. Paul Dragul's Profile - Extended version..
https://health.usnews.com/doctors/paul-dragul-530748
As I believe there are more benevolent stockholders on this board as apposed to the malevolent who perpetually pummeling a company with negativity, I humbly submit that Dr. Paul Dragul is an ENT-Otolaryngologist https://health.usnews.com/doctors/paul-dragul-530748
specializing in Head and Neck Surgery including Ear, Nose and Throat regions of the human anatomy.https://en.wikipedia.org/wiki/Otorhinolaryngology
The Center of Disease Control reports that 480,000 deaths a year in the US, equating to 1 in 5, that can be directly attributed to Cigarette Smoking.
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm
Although we all make choices in life and have to live with the consequences, I highly doubt that any company would engage the expertise of a 4 Decade Medical Surgeon if he has not witnessed the the improved quality of life for his patients.......
Perhaps, it is he we should thank for endeavoring to process and titrate CBD Oil down to a predictable and prescribed dosage while factoring in all pharmaceutical standards.
In Closing, I suspect that our good Doctor has seen more cancer than he would have ever wanted to witness or operate on.....and therefore I submit this last link from The National Library of Medicine entitled:
"A Users Guide To Cannabinoid Therapies In Oncology"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Again, the true upwards trajectory of both patients and investors is $OON
JC799
merging with an amazing company
JUST ONE MORE DAY TO LOAD GRCK, AND THATS TOMMORROW...NEXT WEEK HUGE FIREWORKS....EXPECTING AT LEAST .10+++.....MEGA-MERGER $$$$$$$$$$
Really, you expect dilution here of 1 billion shares??? LOL LOL
Yes, where was that rally that the pump 8K was supposed to spark?
Oh, I forgot... last week it spiked...
NEVER BUY THE BACK SIDE OF A SPIKE CHART!
Tradubg 101.... next...
At least we're not trading at .006 and we don't have an O/S of 1 Billion like that cheap diluted wine stock.
NEXT
Indeed, those that bought last week at .025 and .03 are hurting here, as 40% losses are huge... next...
Followers
|
112
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
17821
|
Created
|
03/29/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |